• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Over $15M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

    7/17/24 8:06:17 AM ET
    $BLND
    $CYAN
    $TKNO
    Computer Software: Programming Data Processing
    Technology
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $BLND alert in real time by email

    The Dow Jones index closed higher by more than 700 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

    Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

    Alpha Teknova

    • The Trade: Alpha Teknova, Inc. (NASDAQ:TKNO) 10% owner Telegraph Hill Partners Management Company, LLC bought a total of 12,096,773 shares at an average price of $1.24. To acquire these shares, it cost around $15 million. The company's Chief Financial Officer bought 40,000 shares, while CEO purchased 80,645 shares of the company.
    • What's Happening: On July 12, Teknova announced a $15.4 million private placement.
    • What Alpha Teknova Does: Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics.

    Cyanotech

    • The Trade: Cyanotech Corporation (OTC:CYAN) Director Michael A / Davis acquired a total of 10,000 shares at an average price of $0.54. To acquire these shares, it cost around $5,400.
    • What's Happening: On June 26, Cyanotech reported net sales of $23,071,000 for fiscal 2024 compared to $23,178,000 in fiscal 2023.
    • What Cyanotech Does: Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market.

    Blend Labs

    • The Trade: Blend Labs, Inc. (NYSE:BLND) Head of Finance and Admin. Amir Jafari acquired a total of 6,666 shares at an average price of $2.54. The insider spent around $ $16,940 to buy those shares.
    • What's Happening: On May 8, Blend Labs posted upbeat quarterly results.
    • What Blend Labs Does: Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers.

    Read Next:

    • Top 4 Risk Off Stocks You’ll Regret Missing In July
    Get the next $BLND alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BLND
    $CYAN
    $TKNO

    CompanyDatePrice TargetRatingAnalyst
    Alpha Teknova Inc.
    $TKNO
    7/22/2025$8.00Overweight
    Stephens
    Alpha Teknova Inc.
    $TKNO
    2/10/2025$12.00Buy
    Craig Hallum
    Blend Labs Inc.
    $BLND
    12/18/2024$7.00Mkt Outperform
    JMP Securities
    Blend Labs Inc.
    $BLND
    8/12/2024$3.00 → $4.75Hold → Buy
    Canaccord Genuity
    Blend Labs Inc.
    $BLND
    8/9/2024Mkt Perform → Outperform
    William Blair
    Alpha Teknova Inc.
    $TKNO
    3/12/2024Buy → Neutral
    BTIG Research
    Blend Labs Inc.
    $BLND
    12/20/2023$1.50 → $3.50Equal Weight → Overweight
    Wells Fargo
    Blend Labs Inc.
    $BLND
    11/14/2022$2.25Underperform → Mkt Perform
    Keefe Bruyette
    More analyst ratings

    $BLND
    $CYAN
    $TKNO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Lowell Matthew bought $87,616 worth of shares (40,000 units at $2.19), increasing direct ownership by 31% to 168,376 units (SEC Form 4)

    4 - Alpha Teknova, Inc. (0001850902) (Issuer)

    3/9/26 4:30:28 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    President and CEO Gunstream Stephen bought $55,801 worth of shares (26,000 units at $2.15), increasing direct ownership by 11% to 269,497 units (SEC Form 4)

    4 - Alpha Teknova, Inc. (0001850902) (Issuer)

    3/9/26 4:24:28 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Haveli Investments, L.P. bought $213,850 worth of shares (69,934 units at $3.06) (SEC Form 4)

    4 - Blend Labs, Inc. (0001855747) (Issuer)

    11/26/25 7:11:55 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    $BLND
    $CYAN
    $TKNO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by General Counsel and CCO Terrill Damon

    4 - Alpha Teknova, Inc. (0001850902) (Issuer)

    3/9/26 4:35:21 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Chief Financial Officer Lowell Matthew bought $87,616 worth of shares (40,000 units at $2.19), increasing direct ownership by 31% to 168,376 units (SEC Form 4)

    4 - Alpha Teknova, Inc. (0001850902) (Issuer)

    3/9/26 4:30:28 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    President and CEO Gunstream Stephen bought $55,801 worth of shares (26,000 units at $2.15), increasing direct ownership by 11% to 269,497 units (SEC Form 4)

    4 - Alpha Teknova, Inc. (0001850902) (Issuer)

    3/9/26 4:24:28 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $BLND
    $CYAN
    $TKNO
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Blend Labs Inc.

    SCHEDULE 13G/A - Blend Labs, Inc. (0001855747) (Subject)

    3/26/26 4:42:27 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    SEC Form S-8 filed by Blend Labs Inc.

    S-8 - Blend Labs, Inc. (0001855747) (Filer)

    3/16/26 4:21:46 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Blend Labs Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Blend Labs, Inc. (0001855747) (Filer)

    3/10/26 4:01:12 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    $BLND
    $CYAN
    $TKNO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Blend Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

    Blend Labs, Inc. (NYSE:BLND), a leading origination platform for digital banking solutions, today announced its preliminary fourth quarter and full year 2025 financial results. Blend also announced that its Board of Directors authorized a share repurchase program providing for the repurchase of up to $50 million of its Class A common stock. "I am pleased to report that Blend finished fiscal year 2025 with a strong fourth quarter, coming in near the high end of our revenue guidance and beating the high end of our non-GAAP operating income guidance," said Nima Ghamsari, Co-founder and Head of Blend. "What excites me most going into 2026 is not just our growing roster of customers — it's wha

    3/10/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Blend Launches Autopilot, Completing Loan Origination Reviews in 15 Seconds

    The first AI agent of Blend Intelligent Origination works inside existing lender workflows and guidelines to deliver real-time compliance review, automated follow-ups, and full borrower visibility from first touch to underwriting Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform for banks, credit unions, and mortgage lenders, today announced the launch of Blend Autopilot, the first agent of Blend Intelligent Origination. Traditional mortgage origination averages 30 to 60 days and costs $11,000 or more per loan; a cycle plagued by batch-oriented review processes where borrowers wait hours or days for a loan officer to review and assess next steps. Blend Autopilot chang

    3/3/26 9:00:00 AM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    $BLND
    $CYAN
    $TKNO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stephens resumed coverage on Alpha Teknova with a new price target

    Stephens resumed coverage of Alpha Teknova with a rating of Overweight and set a new price target of $8.00

    7/22/25 7:51:11 AM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Craig Hallum initiated coverage on Alpha Teknova with a new price target

    Craig Hallum initiated coverage of Alpha Teknova with a rating of Buy and set a new price target of $12.00

    2/10/25 8:24:48 AM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    JMP Securities initiated coverage on Blend Labs with a new price target

    JMP Securities initiated coverage of Blend Labs with a rating of Mkt Outperform and set a new price target of $7.00

    12/18/24 7:26:16 AM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    $BLND
    $CYAN
    $TKNO
    Leadership Updates

    Live Leadership Updates

    View All

    Blend Announces Finance Leadership Transition

    Head of Blend taps Jason Ream to help lead next phase of growth and profitability Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform for banks, credit unions, and mortgage lenders, today announced that Jason Ream, an experienced strategic financial leader, will join as the Company's Head of Finance and Administration by August 8, 2025. Jason Ream has over 25 years of experience as a financial and operating leader in technology and software. Jason previously served as the CFO of two public companies, SailPoint Technologies Holdings, Inc. and SolarWinds Corporation, as well as two private companies, Mitratech Holdings Inc. and Relativity ODA LLC. Prior to joining Blend h

    8/7/25 4:05:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Blend Appoints CU Veteran Reva Rao as Head of Digital Transformation for Credit Unions

    Industry powerhouse brings deep expertise to strengthen Blend's solutions and value to credit union digital leadership Blend Labs, Inc. (NYSE:BLND), a leading origination platform for digital banking solutions, today announced the appointment of Reva Rao as Head of Digital Transformation for Credit Unions. Rao brings over two decades of experience in financial services, with extensive leadership roles at prominent credit unions including Travis Credit Union and Golden 1 Credit Union. Her deep understanding of credit union operations and member-centric approach will be instrumental in driving Blend's mission to help credit unions deliver exceptional digital experiences. This appointmen

    6/4/25 6:00:00 AM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Srini Venkatramani Joins Blend As Head of Product, Technology, and Customer Operations

    Seasoned executive to propel Blend's next phase of product innovation and growth Blend Labs, Inc. (NYSE:BLND), a leading platform for digital banking solutions, today announced the appointment of Srini Venkatramani as Head of Product, Technology, and Customer Operations. Srini's leadership will be instrumental in accelerating Blend's next phase of growth in the digital banking space. With over 23 years of experience, Srini joins Blend with a proven track record of scaling SaaS businesses, driving product innovation, and delivering accelerated value creation for stakeholders. In his role as Head of Product, Technology, and Customer Operations, he will orchestrate the company's product vi

    12/9/24 4:05:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    $BLND
    $CYAN
    $TKNO
    Financials

    Live finance-specific insights

    View All

    Blend Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

    Blend Labs, Inc. (NYSE:BLND), a leading origination platform for digital banking solutions, today announced its preliminary fourth quarter and full year 2025 financial results. Blend also announced that its Board of Directors authorized a share repurchase program providing for the repurchase of up to $50 million of its Class A common stock. "I am pleased to report that Blend finished fiscal year 2025 with a strong fourth quarter, coming in near the high end of our revenue guidance and beating the high end of our non-GAAP operating income guidance," said Nima Ghamsari, Co-founder and Head of Blend. "What excites me most going into 2026 is not just our growing roster of customers — it's wha

    3/10/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Teknova Reports Fourth Quarter and Full Year 2025 Financial Results

    Full year 2025 total revenue was $40.5 million, up 7% year-over-year and in line with guidanceFourth quarter 2025 total revenue was $10.0 million, up 8% over the same quarter prior yearCompany provides 2026 revenue guidance of $42-44 million HOLLISTER, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. ("Teknova" or the "Company") (NASDAQ:TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced financial results for the fourth quarter and full year ended December 31, 2025. "After another successful year of disciplined execution against our strategic objectives,

    2/26/26 4:01:00 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $BLND
    $CYAN
    $TKNO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Blend Labs Inc.

    SC 13G/A - Blend Labs, Inc. (0001855747) (Subject)

    11/12/24 1:31:39 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Blend Labs Inc.

    SC 13G/A - Blend Labs, Inc. (0001855747) (Subject)

    11/7/24 4:38:48 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Blend Labs Inc.

    SC 13G/A - Blend Labs, Inc. (0001855747) (Subject)

    11/4/24 11:26:46 AM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology